Laurus Labs informs about company updates

29 Oct 2022 Evaluate
Laurus Labs has informed that US Food and Drug Administration (USFDA) today completed a Pre-Approval Inspection (PAI) at its manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 24th October 2022 to 28th October 2022. The company issued a Form 483 with one observation. The observation is procedural in nature. The Company will address the observation within stipulated timelines.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

586.40 15.60 (2.73%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.